SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2021 Biotech Stock Picking Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Aloner8/23/2021 4:39:24 PM
   of 307
 
Today, Cramer says BUY Oncology stocks. As if we didn't know that. I don't watch or follow him, just saw this article:

Pfizer Inc. (NYSE: PFE) announced Monday that it entered into a definitive agreement to acquire Trillium Therapeutics Inc (NASDAQ: TRIL) for an implied equity value of $2.26 billion, or $18.50 per share.

Pfizer's acquisition of Trillium is just the beginning of the company putting money to work in order to eliminate its patent cliff, Jim Cramer said Monday on CNBC's "Squawk On The Street."

Cramer expects "many acquisitions" to follow so that Pfizer can eliminate longer-term worry from investors.

Pfizer has "endless firepower" and the company is going to use it, Cramer said.

"If it's an oncological franchise, buy the stock," he said: "Every major company believes that is still where you can make the most money."

Trillium has a terrific oncological platform, Cramer noted. Trillium is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer.

Cramer told CNBC that investors should pay close attention to oncological stocks that have been beaten down and are about to start trials.

PFE Price Action: Pfizer has traded as high as $51.86 and as low as $32.80 over a 52-week period.

At last check Monday, the stock was up 2.76% at $50.28.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News